NLRP3 and obesity disorder: Elevated IL-1β and IL-18 levels are consistently observed in the adipose tissue and serum of individuals with obesity and insulin resistance [64,67,97], and higher NLRP3 expression in visceral adipose tissue correlates with the severity of insulin resistance [45,67].